Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 6 studies | 29% ± 9% | |
endothelial cell | 5 studies | 22% ± 5% | |
retinal cone cell | 5 studies | 35% ± 18% | |
retinal rod cell | 4 studies | 21% ± 4% | |
astrocyte | 4 studies | 26% ± 4% | |
glutamatergic neuron | 4 studies | 30% ± 9% | |
neuron | 4 studies | 24% ± 9% | |
oligodendrocyte | 4 studies | 20% ± 2% | |
epithelial cell | 3 studies | 16% ± 1% | |
GABAergic neuron | 3 studies | 31% ± 6% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1473.12 | 2642 / 2642 | 100% | 43.61 | 705 / 705 |
esophagus | 100% | 840.75 | 1445 / 1445 | 100% | 19.46 | 183 / 183 |
ovary | 100% | 652.65 | 180 / 180 | 100% | 26.76 | 430 / 430 |
skin | 100% | 814.02 | 1809 / 1809 | 100% | 30.73 | 472 / 472 |
stomach | 100% | 650.60 | 359 / 359 | 100% | 21.62 | 286 / 286 |
lung | 100% | 804.76 | 577 / 578 | 100% | 22.18 | 1155 / 1155 |
intestine | 100% | 892.49 | 966 / 966 | 100% | 20.26 | 526 / 527 |
prostate | 100% | 749.90 | 245 / 245 | 100% | 17.98 | 501 / 502 |
uterus | 100% | 924.02 | 170 / 170 | 100% | 24.56 | 458 / 459 |
kidney | 100% | 809.13 | 89 / 89 | 100% | 18.11 | 899 / 901 |
breast | 100% | 858.50 | 459 / 459 | 100% | 22.51 | 1114 / 1118 |
bladder | 100% | 904.67 | 21 / 21 | 100% | 19.65 | 502 / 504 |
adrenal gland | 100% | 1337.52 | 258 / 258 | 100% | 32.31 | 229 / 230 |
thymus | 100% | 749.24 | 652 / 653 | 100% | 21.42 | 603 / 605 |
pancreas | 97% | 372.23 | 317 / 328 | 99% | 19.06 | 177 / 178 |
liver | 95% | 331.00 | 214 / 226 | 98% | 13.65 | 399 / 406 |
adipose | 100% | 856.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 22.57 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.33 | 29 / 29 |
spleen | 100% | 971.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.45 | 1 / 1 |
blood vessel | 100% | 954.07 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 579.74 | 849 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 395.02 | 772 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 780.83 | 883 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007601 | Biological process | visual perception |
GO_0005929 | Cellular component | cilium |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005095 | Molecular function | GTPase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | PDE6D |
Protein name | Phosphodiesterase 6D Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta) (Protein p17) |
Synonyms | hCG_32951 PDED tmp_locus_12 |
Description | FUNCTION: Promotes the release of prenylated target proteins from cellular membranes . Modulates the activity of prenylated or palmitoylated Ras family members by regulating their subcellular location . Required for normal ciliary targeting of farnesylated target proteins, such as INPP5E . Modulates the subcellular location of target proteins by acting as a GTP specific dissociation inhibitor (GDI) (By similarity). Increases the affinity of ARL3 for GTP by several orders of magnitude. Stabilizes ARL3-GTP by decreasing the nucleotide dissociation rate (By similarity). . FUNCTION: Promotes the release of prenylated target proteins from cellular membranes. Modulates the activity of prenylated or palmitoylated Ras family members by regulating their subcellular location. Required for normal ciliary targeting of farnesylated target proteins, such as INPP5E. Modulates the subcellular location of target proteins by acting as a GTP specific dissociation inhibitor (GDI). Increases the affinity of ARL3 for GTP by several orders of magnitude. Stabilizes ARL3-GTP by decreasing the nucleotide dissociation rate. . |
Accessions | B8ZZK5 ENST00000428104.2 Q6IB24 O43924 ENST00000287600.9 C9IZ52 ENST00000409772.5 |